MetaCap

Dianthus Therapeutics Insider Trades

NASDAQ: DNTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD

82.37-0.06 (-0.07%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
62 · $63.82M
Shares bought / sold
0 / 702.02K
Net activity
Net selling $63.8 million

Dianthus Therapeutics insider activity

Over the last 12 months, Dianthus Therapeutics insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 62 sales. Insiders bought $0 and sold $63.8 million worth of stock, for net insider selling of $63.8 million. The largest seller was Garcia Marino, with $28.0 million in reported sales.

The most recent filing shows CARR EDWARD (CHIEF ACCOUNTING OFFICER) reporting a transaction in 20,000 shares at $17.88 on Sep 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put DNTH's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

DNTH insider transactions

Dianthus Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 17, 2026CARR EDWARDCHIEF ACCOUNTING OFFICERSale700$73.07KForm 4
Sep 17, 2026CARR EDWARDCHIEF ACCOUNTING OFFICERSale1,100$113.52KForm 4
Sep 17, 2026CARR EDWARDCHIEF ACCOUNTING OFFICERSale3,501$358.47KForm 4
Sep 17, 2026CARR EDWARDCHIEF ACCOUNTING OFFICERSale6,771$686.38KForm 4
Sep 17, 2026CARR EDWARDCHIEF ACCOUNTING OFFICERSale7,928$796.21KForm 4
Sep 17, 2026CARR EDWARDCHIEF ACCOUNTING OFFICEROption exercise20,000$357.60KForm 4
Sep 1, 2026Randhawa SimratEVP, Head of R&DSale13,309$1.42MForm 4
Sep 1, 2026Randhawa SimratEVP, Head of R&DSale7,215$766.59KForm 4
Sep 1, 2026Randhawa SimratEVP, Head of R&DSale2,600$273.49KForm 4
Sep 1, 2026Randhawa SimratEVP, Head of R&DOption exercise9,375$206.91KForm 4
Sep 1, 2026Randhawa SimratEVP, Head of R&DOption exercise6,249$136.04KForm 4
Sep 1, 2026Randhawa SimratEVP, Head of R&DOption exercise7,500$134.10KForm 4
Aug 19, 2026Read SimonDirectorSale2,778$326.55KForm 4
Aug 19, 2026Read SimonDirectorOption exercise2,778$51.00KForm 4
Aug 13, 2026Veness Adam MSVP, General Counsel and Sec.Option exercise15,000$272.55KForm 4
Aug 10, 2026Veness Adam MSVP, General Counsel and Sec.Sale16,167$1.78MForm 4
Aug 10, 2026Veness Adam MSVP, General Counsel and Sec.Option exercise16,167$289.07KForm 4
Aug 10, 2026Read SimonDirectorSale397$44.37KForm 4
Aug 10, 2026Read SimonDirectorSale470$52.19KForm 4
Aug 10, 2026Read SimonDirectorSale272$29.91KForm 4
Aug 10, 2026Read SimonDirectorSale831$90.54KForm 4
Aug 10, 2026Read SimonDirectorSale737$79.72KForm 4
Aug 10, 2026Read SimonDirectorSale70$7.50KForm 4
Aug 10, 2026Read SimonDirectorOption exercise2,777$50.99KForm 4
Aug 10, 2026McGeorge AnneDirectorSale700$77.99KForm 4
Aug 10, 2026McGeorge AnneDirectorSale1,000$110.64KForm 4
Aug 10, 2026McGeorge AnneDirectorSale1,800$196.74KForm 4
Aug 10, 2026McGeorge AnneDirectorSale2,800$303.46KForm 4
Aug 10, 2026McGeorge AnneDirectorSale1,450$155.99KForm 4
Aug 10, 2026McGeorge AnneDirectorOption exercise6,500$72.80KForm 4
Aug 10, 2026McGeorge AnneDirectorOption exercise1,250$24.20KForm 4
Aug 7, 2026Garcia MarinoCEO AND PRESIDENTSale21,909$2.38MForm 4
Aug 7, 2026Garcia MarinoCEO AND PRESIDENTSale104,091$11.24MForm 4
Aug 7, 2026Garcia MarinoCEO AND PRESIDENTSale800$88.61KForm 4
Aug 7, 2026Garcia MarinoCEO AND PRESIDENTSale2,536$279.01KForm 4
Aug 7, 2026Garcia MarinoCEO AND PRESIDENTSale2,373$258.89KForm 4
Aug 7, 2026Garcia MarinoCEO AND PRESIDENTSale23,907$2.58MForm 4
Aug 7, 2026Garcia MarinoCEO AND PRESIDENTSale10,384$1.12MForm 4
Aug 7, 2026Garcia MarinoCEO AND PRESIDENTOption exercise126,000$1.06MForm 4
Aug 7, 2026Garcia MarinoCEO AND PRESIDENTOption exercise40,000$337.60KForm 4
Aug 7, 2026Veness Adam MSVP, General Counsel and Sec.Sale616$68.49KForm 4
Aug 7, 2026Veness Adam MSVP, General Counsel and Sec.Sale3,217$355.83KForm 4
Aug 7, 2026Veness Adam MSVP, General Counsel and Sec.Option exercise3,833$68.53KForm 4
Jul 9, 2026Savitz RyanEVP, CFO & CBOSale5,566$567.57KForm 4
Jul 9, 2026Savitz RyanEVP, CFO & CBOSale15,329$1.55MForm 4
Jul 9, 2026Savitz RyanEVP, CFO & CBOSale10,354$1.04MForm 4
Jul 9, 2026Savitz RyanEVP, CFO & CBOOption exercise31,249$680.29KForm 4
Jun 17, 2026Veness Adam MSVP, General Counsel and Sec.Sale13,229$1.08MForm 4
Jun 17, 2026Veness Adam MSVP, General Counsel and Sec.Sale16,771$1.35MForm 4
Jun 17, 2026Veness Adam MSVP, General Counsel and Sec.Option exercise30,000$536.40KForm 4
Jun 1, 2026Randhawa SimratEVP, Head of R&DSale4,159$380.01KForm 4
Jun 1, 2026Randhawa SimratEVP, Head of R&DSale16,943$1.54MForm 4
Jun 1, 2026Randhawa SimratEVP, Head of R&DSale5,428$487.00KForm 4
Jun 1, 2026Randhawa SimratEVP, Head of R&DOption exercise9,375$206.91KForm 4
Jun 1, 2026Randhawa SimratEVP, Head of R&DOption exercise6,249$136.04KForm 4
Jun 1, 2026Randhawa SimratEVP, Head of R&DOption exercise6,908$123.52KForm 4
Jun 1, 2026Randhawa SimratEVP, Head of R&DOption exercise3,998$33.74KForm 4
May 8, 2026Soteropoulos PaulaDirectorSale599$51.20KForm 4
May 8, 2026Soteropoulos PaulaDirectorOption exercise599$5.06KForm 4
Apr 9, 2026Savitz RyanEVP, CFO & CBOSale8,224$738.84KForm 4
Apr 9, 2026Savitz RyanEVP, CFO & CBOOption exercise8,224$147.05KForm 4
Mar 31, 2026Savitz RyanEVP, CFO & CBOSale7,232$618.63KForm 4
Mar 31, 2026Savitz RyanEVP, CFO & CBOSale19,469$1.65MForm 4
Mar 31, 2026Savitz RyanEVP, CFO & CBOSale59,800$5.02MForm 4
Mar 31, 2026Savitz RyanEVP, CFO & CBOSale2,366$196.00KForm 4
Mar 31, 2026Savitz RyanEVP, CFO & CBOSale800$65.09KForm 4
Mar 31, 2026Savitz RyanEVP, CFO & CBOSale1,485$119.17KForm 4
Mar 31, 2026Savitz RyanEVP, CFO & CBOSale21,825$1.72MForm 4
Mar 31, 2026Savitz RyanEVP, CFO & CBOSale1,390$108.88KForm 4
Mar 31, 2026Savitz RyanEVP, CFO & CBOOption exercise40,000$715.20KForm 4
Mar 31, 2026Savitz RyanEVP, CFO & CBOOption exercise74,367$627.66KForm 4
Mar 31, 2026Soteropoulos PaulaDirectorSale599$47.99KForm 4
Mar 31, 2026Soteropoulos PaulaDirectorOption exercise599$5.06KForm 4
Mar 24, 2026Soteropoulos PaulaDirectorSale27,594$2.15MForm 4
Mar 24, 2026Soteropoulos PaulaDirectorOption exercise27,594$232.89KForm 4
Mar 16, 2026Garcia MarinoCEO AND PRESIDENTOption exercise5,592$99.98KForm 4
Mar 16, 2026Garcia MarinoCEO AND PRESIDENTOption exercise59,700$399.99KForm 4
Mar 12, 2026CARR EDWARDCHIEF ACCOUNTING OFFICERSale300$25.66KForm 4
Mar 12, 2026CARR EDWARDCHIEF ACCOUNTING OFFICERSale200$16.68KForm 4
Mar 12, 2026CARR EDWARDCHIEF ACCOUNTING OFFICERSale3,865$319.48KForm 4
Mar 12, 2026CARR EDWARDCHIEF ACCOUNTING OFFICERSale23,465$1.92MForm 4
Mar 12, 2026CARR EDWARDCHIEF ACCOUNTING OFFICERSale15,852$1.28MForm 4
Mar 12, 2026CARR EDWARDCHIEF ACCOUNTING OFFICEROption exercise10,000$217.70KForm 4
Mar 12, 2026CARR EDWARDCHIEF ACCOUNTING OFFICEROption exercise17,500$386.23KForm 4
Mar 12, 2026CARR EDWARDCHIEF ACCOUNTING OFFICEROption exercise16,182$289.33KForm 4
Mar 12, 2026Randhawa SimratEVP, Head of R&DSale33,830$2.76MForm 4
Mar 12, 2026Randhawa SimratEVP, Head of R&DOption exercise12,500$275.88KForm 4
Mar 12, 2026Randhawa SimratEVP, Head of R&DOption exercise8,332$181.39KForm 4
Mar 12, 2026Randhawa SimratEVP, Head of R&DOption exercise5,000$89.40KForm 4
Mar 12, 2026Randhawa SimratEVP, Head of R&DOption exercise7,998$67.50KForm 4
Mar 12, 2026Garcia MarinoCEO AND PRESIDENTSale900$76.98KForm 4
Mar 12, 2026Garcia MarinoCEO AND PRESIDENTSale200$16.68KForm 4
Mar 12, 2026Garcia MarinoCEO AND PRESIDENTSale12,796$1.06MForm 4
Mar 12, 2026Garcia MarinoCEO AND PRESIDENTSale65,517$5.36MForm 4
Mar 12, 2026Garcia MarinoCEO AND PRESIDENTSale43,505$3.51MForm 4
Mar 12, 2026Garcia MarinoCEO AND PRESIDENTOption exercise122,918$823.55KForm 4
Dec 4, 2025Savitz RyanCFO & CBOSale20,000$903.60KForm 4
Dec 4, 2025Savitz RyanCFO & CBOOption exercise20,000$168.80KForm 4
Nov 14, 2025Randhawa SimratEVP, Head of R&DOption exercise37,494$816.24KForm 4
Nov 14, 2025Randhawa SimratEVP, Head of R&DOption exercise40,287$720.33KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related